Factor IX gene therapy for haemophilia B

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1391, 2003-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factor VIII gene therapy: promising phase I results in haemophilia A

By  

Inpharma, Vol. 1, Iss. 1292, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Gene therapy for haemophilia?

By  

Inpharma, Vol. 1, Iss. 1292, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Gene therapy trials in the UK: is haemophilia a suitable 'model'?

By  

Clinical Medicine, Vol. 4, Iss. 1, 2004-01 ,pp. : 54-56

Royal College Of Physicians

Access to resources Recommend Favorite

Recombinant Factor VIIa (Eptacog Alfa): A Pharmacoeconomic Review of its Use in Haemophilia in Patients with Inhibitors to Clotting Factors VIII or IX

By Lyseng-Williamson Katherine A.   Plosker Greg L.  

PharmacoEconomics, Vol. 25, Iss. 12, 2007-01 ,pp. : 1007-1029

Adis International

Access to resources Recommend Favorite

TGF-&bgr;: A Fibrotic Factor in Wound Scarring and a Potential Target for Anti- Scarring Gene Therapy

By  

Current Gene Therapy, Vol. 4, Iss. 1, 2004-03 ,pp. : 123-136

Bentham Science Publishers

Access to resources Recommend Favorite